Long non‑coding RNA lung cancer‑associated transcript 1 regulates ferroptosis via microRNA‑34a‑5p‑mediated GTP cyclohydrolase 1 downregulation in lung cancer cells

Tai,Fumin; Tai,Fumin; Zhai,Rui; Zhai,Rui; Ding,Kexin; Ding,Kexin; Zhang,Yaocang; Zhang,Yaocang; Yang,Hexi; Yang,Hexi; Li,Hujie; Li,Hujie; Wang,Qiong; Wang,Qiong; Cao,Zhengyue; Cao,Zhengyue; Ge,Changhui; Ge,Changhui; Fu,Hanjiang; Fu,Hanjiang; Xiao,Fengjun; Xiao,Fengjun; Zheng,Xiaofei; Zheng,Xiaofei

doi:10.3892/ijo.2024.5652

Long non‑coding RNA lung cancer‑associated transcript 1 regulates ferroptosis via microRNA‑34a‑5p‑mediated GTP cyclohydrolase 1 downregulation in lung cancer cells

Authors:
- Fumin Tai
- Rui Zhai
- Kexin Ding
- Yaocang Zhang
- Hexi Yang
- Hujie Li
- Qiong Wang
- Zhengyue Cao
- Changhui Ge
- Hanjiang Fu
- Fengjun Xiao
- Xiaofei Zheng
View Affiliations

Affiliations: Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, P.R. China
Published online on: May 10, 2024 https://doi.org/10.3892/ijo.2024.5652
Article Number: 64
Copyright: © Tai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ferroptosis, a recently discovered type of programmed cell death triggered by excessive accumulation of iron‑dependent lipid peroxidation, is linked to several malignancies, including non‑small cell lung cancer. Long non‑coding RNAs (lncRNAs) are involved in ferroptosis; however, data on their role and mechanism in cancer therapy remains limited. Therefore, the aim of the present study was to identify ferroptosis‑associated mRNAs and lncRNAs in A549 lung cancer cells treated with RAS‑selective lethal 3 (RSL3) and ferrostatin‑1 (Fer‑1) using RNA sequencing. The results demonstrated that lncRNA lung cancer‑associated transcript 1 (LUCAT1) was significantly upregulated in lung adenocarcinoma and lung squamous cell carcinoma tissues. Co‑expression analysis of differentially expressed mRNAs and lncRNAs suggested that LUCAT1 has a crucial role in ferroptosis. LUCAT1 expression was markedly elevated in A549 cells treated with RSL3, which was prevented by co‑incubation with Fer‑1. Functionally, overexpression of LUCAT1 facilitated cell proliferation and reduced the occurrence of ferroptosis induced by RSL3 and Erastin, while inhibition of LUCAT1 expression reduced cell proliferation and increased ferroptosis. Mechanistically, downregulation of LUCAT1 resulted in the downregulation of both GTP cyclohydrolase 1 (GCH1) and ferroptosis suppressor protein 1 (FSP1). Furthermore, inhibition of LUCAT1 expression upregulated microRNA (miR)‑34a‑5p and then downregulated GCH1. These results indicated that inhibition of LUCAT1 expression promoted ferroptosis by modulating the downregulation of GCH1, mediated by miR‑34a‑5p. Therefore, the combination of knocking down LUCAT1 expression with ferroptosis inducers may be a promising strategy for lung cancer treatment.

View Figures

View References

1	Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. 2012.
2	Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
3	Seibt TM, Proneth B and Conrad M: Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 133:144–152. 2019.
4	Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 575:688–692. 2019.
5	Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 575:693–698. 2019.
6	Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X, Anastasov N, Kössl J, et al: GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 6:41–53. 2020.
7	Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, et al: DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 593:586–590. 2021.
8	Dolma S, Lessnick SL, Hahn WC and Stockwell BR: Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 3:285–296. 2003.
9	Yang WS and Stockwell BR: Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 15:234–245. 2008.
10	Miotto G, Rossetto M, Di Paolo ML, Orian L, Venerando R, Roveri A, Vučković AM, Bosello Travain V, Zaccarin M, Zennaro L, et al: Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 28:1013282020.
11	Hassannia B, Vandenabeele P and Vanden Berghe T: Targeting ferroptosis to iron out cancer. Cancer Cell. 35:830–849. 2019.
12	Lei G, Zhuang L and Gan B: Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 22:381–396. 2022.
13	Kino T, Hurt DE, Ichijo T, Nader N and Chrousos GP: Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 3:ra82010.
14	Karreth FA, Tay Y, Perna D, Ala U, Tan SM, Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, et al: In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell. 147:382–395. 2011.
15	Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as modular scaffold of histone modification complexes. Science. 329:689–693. 2010.
16	Huarte M: The emerging role of lncRNAs in cancer. Nat Med. 21:1253–1261. 2015.
17	Zhang R, Pan T, Xiang Y, Zhang M, Xie H, Liang Z, Chen B, Xu C, Wang J, Huang X, et al: Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis. Bioact Mater. 13:23–36. 2021.
18	Qin Y, Zhang D, Zhang H, Hou L, Wang Z, Yang L, Zhang M, Zhao G, Yao Q, Ling R and Zhang J: Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Cancer Cell Int. 22:2962022.
19	Thai P, Statt S, Chen CH, Liang E, Campbell C and Wu R: Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J Respir Cell Mol Biol. 49:204–211. 2013.
20	Jiao Y, Li Y, Ji B, Cai H and Liu Y: Clinical value of lncRNA LUCAT1 expression in liver cancer and its potential pathways. J Gastrointestin Liver Dis. 28:439–447. 2019.
21	Chi J, Liu T, Shi C, Luo H, Wu Z, Xiong B, Liu S and Zeng Y: Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis. Biomed Pharmacother. 118:1092012019.
22	Huan L, Guo T, Wu Y, Xu L, Huang S, Xu Y, Liang L and He X: Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response. Mol Cancer. 19:112020.
23	Zhou Q, Hou Z, Zuo S, Zhou X, Feng Y, Sun Y and Yuan X: LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52. Cancer Sci. 110:1194–1207. 2019.
24	Wang Y, Li Z, Li W, Zhou L and Jiang Y: Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis. Medicine (Baltimore). 98:e172762019.
25	Shu X, Zhang Z, Yao ZY and Xing XL: Identification of five ferroptosis-related lncRNAs as novel prognosis and diagnosis signatures for renal cancer. Front Mol Biosci. 8:7636972022.
26	Xing XL, Yao ZY, Ou J, Xing C and Li F: Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma. Cancer Cell Int. 21:5912021.
27	He Y, Ye Y, Tian W and Qiu H: A novel lncRNA panel related to ferroptosis, tumor progression, and microenvironment is a robust prognostic indicator for glioma patients. Front Cell Dev Biol. 9:7884512021.
28	Deng SH, Wu DM, Li L, Liu T, Zhang T, Li J, Yu Y, He M, Zhao YY, Han R and Xu Y: miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549. Biochem Biophys Res Commun. 549:54–60. 2021.
29	Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H and Gan B: The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 30:146–162. 2020.
30	Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C and Chanda SK: Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 10:15232019.
31	Wang P, Guo Q, Qi Y, Hao Y, Gao Y, Zhi H, Zhang Y, Sun Y, Zhang Y, Xin M, et al: LncACTdb 3.0: An updated database of experimentally supported ceRNA interactions and personalized networks contributing to precision medicine. Nucleic Acids Res. 50(D1): D183–D189. 2022.
32	Li T, Chen B, Yang P, Wang D, Du B and Kang L: Long non-coding RNA derived from lncRNA-mRNA co-expression networks modulates the locust phase change. Genomics Proteomics Bioinformatics. 18:664–678. 2020.
33	Lin Y, Pan X and Shen HB: lncLocator 2.0: A cell-line-specific subcellular localization predictor for long non-coding RNAs with interpretable deep learning. Bioinformatics. 37:2308–2316. 2021.
34	Zhang X, Du L, Qiao Y, Zhang X, Zheng W, Wu Q, Chen Y, Zhu G, Liu Y, Bian Z, et al: Ferroptosis is governed by differential regulation of transcription in liver cancer. Redox Biol. 24:1012112019.
35	Gao R, Buechel D, Kalathur RKR, Morini MF, Coto-Llerena M, Ercan C, Piscuoglio S, Chen Q, Blumer T, Wang X, et al: USP29-mediated HIF1α stabilization is associated with sorafenib resistance of hepatocellular carcinoma cells by upregulating glycolysis. Oncogenesis. 10:522021.
36	Karagkouni D, Paraskevopoulou MD, Tastsoglou S, Skoufos G, Karavangeli A, Pierros V, Zacharopoulou E and Hatzigeorgiou AG: DIANA-LncBase v3: Indexing experimentally supported miRNA targets on non-coding transcripts. Nucleic Acids Res. 48(D1): D101–D110. 2020.
37	Chen Y and Wang X: miRDB: An online database for prediction of functional microRNA targets. Nucleic Acids Res. 48(D1): D127–D131. 2020.
38	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
39	Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by GPX4. Cell. 156:317–331. 2014.
40	Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 520:57–62. 2015.
41	Kwon MY, Park E, Lee SJ and Chung SW: Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 6:24393–24403. 2015.
42	Tian Y, Lu J, Hao X, Li H, Zhang G, Liu X, Li X, Zhao C, Kuang W, Chen D and Zhu M: FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson's disease. Neurotherapeutics. 17:1796–1812. 2020.
43	Dong H, Zhang C, Shi D, Xiao X, Chen X, Zeng Y, Li X and Xie R: Ferroptosis related genes participate in the pathogenesis of spinal cord injury via HIF-1 signaling pathway. Brain Res Bull. 192:192–202. 2023.
44	Cao Y, Luo F, Peng J, Fang Z, Liu Q and Zhou S: KMT2B-dependent RFK transcription activates the TNF-α/NOX2 pathway and enhances ferroptosis caused by myocardial ischemia-reperfusion. J Mol Cell Cardiol. 173:75–91. 2022.
45	Liu H, Zhang B, Chen S, Zhang Y, Ye X, Wei Y, Zhong G and Zhang L: Identification of ferroptosis-associated genes exhibiting altered expression in response to cardiopulmonary bypass during corrective surgery for pediatric tetralogy of fallot. Sci Prog. 104:3685042110502752021.
46	Koyanagi A, Kotani H, Iida Y, Tanino R, Kartika ID, Kishimoto K and Harada M: Protective roles of cytoplasmic p21^Cip1/Waf1 in senolysis and ferroptosis of lung cancer cells. Cell Prolif. 55:e133262022.
47	Deng H, Lin Y, Gan F, Li B, Mou Z, Qin X, He X and Meng Y: Prognostic model and immune infiltration of ferroptosis subcluster-related modular genes in gastric cancer. J Oncol. 2022:58135222022.
48	Jehl A, Conrad O, Burgy M, Foppolo S, Vauchelles R, Ronzani C, Etienne-Selloum N, Chenard MP, Danic A, Dourlhes T, et al: Blocking EREG/GPX4 sensitizes head and neck cancer to cetuximab through ferroptosis induction. Cells. 12:7332023.
49	Ji HZ, Chen L, Ren M, Li S, Liu TY, Chen HJ, Yu HH and Sun Y: CXCL8 promotes endothelial-to-mesenchymal transition of endothelial cells and protects cells from Erastin-induced ferroptosis via CXCR2-mediated activation of the NF-κB signaling pathway. Pharmaceuticals (Basel). 16:12102023.
50	Sun K, Hou L, Guo Z, Wang G, Guo J, Xu J, Zhang X and Guo F: JNK-JUN-NCOA4 axis contributes to chondrocyte ferroptosis and aggravates osteoarthritis via ferritinophagy. Free Radic Biol Med. 200:87–101. 2023.
51	Ko J, Jang S, Kwon W, Kim SY, Jang S, Kim E, Ji YR, Park S, Kim MO, Choi SK, et al: Protective effect of GIP against monosodium glutamate-induced ferroptosis in mouse hippocampal HT-22 cells through the MAPK signaling pathway. Antioxidants (Basel). 11:1892022.
52	Zhu L, Cao P, Yang S, Lin F and Wang J: Prolonged exposure to environmental levels of microcystin-LR triggers ferroptosis in brain via the activation of Erk/MAPK signaling pathway. Ecotoxicol Environ Saf. 267:1156512023.
53	Wang W, Zhu L, Li H, Ren W, Zhuo R, Feng C, He Y, Hu Y and Ye C: Alveolar macrophage-derived exosomal tRF-22-8BWS7K092 activates Hippo signaling pathway to induce ferroptosis in acute lung injury. Int Immunopharmacol. 107:1086902022.
54	Chen J, Chen Z, Yu D, Yan Y, Hao X, Zhang M and Zhu T: Neuroprotective effect of hydrogen sulfide subchronic treatment against TBI-induced ferroptosis and cognitive deficits mediated through Wnt signaling pathway. Cell Mol Neurobiol. 43:4117–4140. 2023.
55	Liu L, Wang M, Gong N, Tian P and Deng H: Se improves GPX4 expression and SOD activity to alleviate heat-stress-induced ferroptosis-like death in goat mammary epithelial cells. Anim Cells Syst (Seoul). 25:283–295. 2021.
56	Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X and Wu C: Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials. 277:1211102021.
57	Matsui M and Corey DR: Non-coding RNAs as drug targets. Nat Rev Drug Discov. 16:167–179. 2017.
58	Chen X, Kang R, Kroemer G and Tang D: Broadening horizons: The role of ferroptosis in cancer. Nat Rev Clin Oncol. 18:280–296. 2021.
59	Qi L, Wang Y, Su S, Wang M, Jablonska E, Jia Y, Wang R, Hao S, Feng C, Li G, et al: Sodium selenite inhibits cervical cancer growth via ROS mediated AMPK/FOXO3a/GADD45a axis. Chem Biol Interact. 367:1101712022.
60	Zhang Y, Luo M, Cui X, O'Connell D and Yang Y: Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p/MIOX axis as a ceRNA. Cell Death Differ. 29:1850–1863. 2022.
61	Wang S, Chen J, Li P and Chen Y: LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-FUS-FSP1 complex. Cell Death Dis. 14:7672023.
62	Bhattacharjee S, Li J and Dashwood RH: Emerging crosstalk between long non-coding RNAs and Nrf2 signaling. Cancer Lett. 490:154–164. 2020.
63	Zhang L, Liu SK, Song L and Yao HR: SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a. Artif Cells Nanomed Biotechnol. 47:556–564. 2019.
64	Wang X, Guo S, Zhao R, Liu Y and Yang G: STAT3-activated long non-coding RNA lung cancer associated transcript 1 drives cell proliferation, migration, and invasion in hepatoblastoma through regulation of the miR-301b/STAT3 axis. Hum Gene Ther. 30:702–713. 2019.
65	Wang L, Tang D, Wu T and Sun F: ELF1-mediated LUCAT1 promotes choroidal melanoma by modulating RBX1 expression. Cancer Med. 9:2160–2170. 2020.
66	Wang L, Xie Y, Wang J, Zhang Y, Liu S, Zhan Y, Zhao Y, Li J, Li P and Wang C: Characterization of a novel LUCAT1/miR-4316/VEGF-A axis in metastasis and glycolysis of lung adenocarcinoma. Front Cell Dev Biol. 10:8335792022.
67	Sun Y, Jin SD, Zhu Q, Han L, Feng J, Lu XY, Wang W, Wang F and Guo RH: Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression. Oncotarget. 8:28297–28311. 2017.
68	Gutierrez-Cruz JA, Maldonado V and Melendez-Zajgla J: Regulation of the cancer stem phenotype by long non-coding RNAs. Cells. 11:23522022.
69	Vierbuchen T, Agarwal S, Johnson JL, Galia L, Lei X, Stein K, Olagnier D, Gaede KI, Herzmann C, Holm CK, et al: The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2. Proc Natl Acad Sci USA. 120:e22137151202023.
70	Tao Y, Liu Q, Wu R, Xiao C, Ni C, Wang K, Hu W, Zhong Z, Zhao J, Li Q, et al: Long noncoding RNA LUCAT1 enhances the survival and therapeutic effects of mesenchymal stromal cells post-myocardial infarction. Mol Ther Nucleic Acids. 27:412–426. 2021.
71	Zhang K, Wang Q, Zhong B and Gong Z: LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR-375 expression. J Cell Mol Med. 25:4543–4550. 2021.
72	Nai Y, Pan C, Hu X and Ma Y: LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539. Cancer Med. 9:757–767. 2020.
73	Liu Z, Gao H, Peng Q and Yang Y: Long noncoding RNA LUCAT1 promotes multiple myeloma cell growth by regulating the TGF-β signaling pathway. Technol Cancer Res Treat. 19:15330338209457702020.
74	Mou E and Wang H: LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702. Biosci Rep. 39:BSR201904892019.
75	Luzón-Toro B, Fernández RM, Martos-Martínez JM, Rubio-Manzanares-Dorado M, Antiñolo G and Borrego S: LncRNA LUCAT1 as a novel prognostic biomarker for patients with papillary thyroid cancer. Sci Rep. 9:143742019.
76	Shen Q, Xu Z and Xu S: Long non-coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR-514a-3p/ULK1 axis in human non-small cell lung cancer. Int J Oncol. 57:967–979. 2020.
77	Han Z and Shi L: Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis. Biochem Biophys Res Commun. 495:947–953. 2018.
78	Cronin SJF, Rao S, Tejada MA, Turnes BL, Licht-Mayer S, Omura T, Brenneis C, Jacobs E, Barrett L, Latremoliere A, et al: Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer. Sci Transl Med. 14:eabj15312022.
79	Sang L, Yang L, Ge Q, Xie S, Zhou T and Lin A: Subcellular distribution, localization, and function of noncoding RNAs. Wiley Interdiscip Rev RNA. 13:e17292022.
80	Li W, Pan T, Jiang W and Zhao H: HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma. Biomed Pharmacother. 129:1102172020.
81	Hao R, Ge J, Song X, Li F, Sun-Waterhouse D and Li D: Cadmium induces ferroptosis and apoptosis by modulating miR-34a-5p/Sirt1axis in PC12 cells. Environ Toxicol. 37:41–51. 2022.